Jochen Seufert

33PUBLICATIONS
63CO-AUTHORS
Gene and molecular therapyNutritional epidemiologyMolecular targetsMetabolic medicinePharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Jun 08, 2026
How does survodutide work? Plain language review of a potential new medication for obesity and liver disease.

|Apr 28, 2026
Weight Loss Strategies Associated With Type 2 Diabetes Duration: A Population-Based Optimal Intervention Window From the NHANES.

|Mar 25, 2026
GLP-1 receptor agonists or SGLT2-inhibitors? Evaluation of a personalized treatment algorithm for individuals with type 2 diabetes: a registry-based cohort study.

Tim Mori, Oliver Kuß, Julia K Mader

|Mar 09, 2026
[Obesity: novel pharmacological treatments].

Jochen Seufert

|Jan 20, 2026
Efficacy and safety of switching basal insulin to insulin glargine 300 U/mL in individuals with inadequately controlled type 2 diabetes on advanced insulin therapies: The Toujeo-Neo T2DM study.

Stefan Pscherer, Andreas Fritsche, Helmut Anderten

|Oct 10, 2025
[Interdisciplinary strategies for the prevention and treatment of MASLD].

Natascha Röhlen, Katharina Laubner, Jochen Seufert

Pageof 6

Frequent Collaborators

7 joint publications

Stefanie Lanzinger

4 joint publications

Peter Bramlage

3 joint publications

Fang Liz Zhou

3 joint publications

Julia K Mader